MYO Insider Trading Activity and SEC Form 4 Filings
MYO insider trading summary
Over the past 12 months, insiders at Myomo, Inc. (MYO) reported 11 open-market purchases worth $269K by 3 insiders and 7 sales worth $201K by 3 insiders on SEC Form 4. Net insider buying was $68K.
Latest MYO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Harry Kovelman | Chief Medical Officer | Sell | $20K (15,488 @ $1.27) |
| Sep 11, 2026 | Harry Kovelman | Chief Medical Officer | Sell | $20K (15,844 @ $1.27) |
| Sep 2, 2026 | Milton Mayo Morris | Insider | Sell | $21K (15,000 @ $1.41) |
| Aug 20, 2026 | Harry Kovelman | Chief Medical Officer | Sell | $30K (17,250 @ $1.73) |
| Jun 5, 2026 | Thomas F Kirk | Insider | Buy | $51K (40,002 @ $1.27) |
| May 28, 2026 | Harry Kovelman | Chief Medical Officer | Sell | $12K (11,536 @ $1.02) |
| May 28, 2026 | Thomas F Kirk | Insider | Buy | $25K (25,000 @ $0.99) |
| May 27, 2026 | Harry Kovelman | Chief Medical Officer | Sell | $21K (20,464 @ $1.00) |
| May 18, 2026 | Thomas F Kirk | Insider | Buy | $39K (43,401 @ $0.91) |
| May 15, 2026 | Thomas F Kirk | Insider | Buy | $29K (31,605 @ $0.91) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.